Significant proportion of cancer drugs lack proof of added benefit, finds study
by British Medical JournalCredit: CC0 Public DomainMany cancer drugs approved by the European Medicines Agency (EMA) between 1995 and 2020 lack proof of added benefit, particularly those approved
Updated on: May 26,2024
3
Significant proportion of cancer drugs lack proof of added benefit, finds study
by British Medical JournalCredit: CC0 Public DomainMany cancer drugs approved by the European Medicines Agency (EMA) between 1995 and 2020 lack proof of added benefit, particularly those approved
Updated on:May 26,2024
3
